Bank of New York Mellon Corp
BankPosition in BMRN — Biomarin Pharmaceutical Inc
CIK 1390777
NEW YORK, NY
Position in BMRN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$66,106,545
+$1,431,603 QoQ
Shares Held
1,155,305
+0.9% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#31
of 561 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 92%
Shared 0%
None 8%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. BMRN ranks #18 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in BMRN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $66,106,545 | 1,155,305 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $64,674,942 | 1,144,892 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $73,113,990 | 1,230,254 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $74,331,127 | 1,372,436 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $75,065,981 | 1,365,581 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $97,450,682 | 1,378,564 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $157,748,903 | 2,399,953 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $163,072,019 | 2,319,989 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $192,495,187 | 2,338,093 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $230,358,196 | 2,637,488 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $246,858,236 | 2,560,239 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $211,921,979 | 2,395,140 | Shares | Other | 2023-10-24 | |
| 2023-06-30 | $189,610,322 | 2,187,475 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $202,225,061 | 2,079,649 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $176,326,152 | 1,703,799 | Shares | Other | 2023-02-14 | |
| 2022-09-30 | $97,142,006 | 1,145,948 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $111,917,088 | 1,350,514 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $57,288,920 | 743,047 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $62,100,149 | 702,888 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $54,482,489 | 704,910 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $57,977,779 | 694,844 | Shares | Other | 2021-08-11 | |
| 2021-03-31 | $53,539,532 | 709,039 | Shares | Other | 2021-05-13 | |
| 2020-12-31 | $65,812,569 | 750,514 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $62,797,265 | 825,411 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $135,546,338 | 1,098,965 | Shares | Other | 2020-08-12 | |
| 2020-03-31 | $63,282,131 | 748,901 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||